AVIDITY BIOSCIENCES Trademark

Trademark Overview

On Monday, February 24, 2020, a trademark application was filed for AVIDITY BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the AVIDITY BIOSCIENCES trademark a serial number of 88808600. The federal status of this trademark filing is REGISTERED as of Tuesday, May 16, 2023. This trademark is owned by Avidity Biosciences, Inc.. The AVIDITY BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological, medicinal and pharmaceutical preparations, namely, oligonucleotide-based therapeutics for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
avidity biosciences

General Information

Serial Number88808600
Word MarkAVIDITY BIOSCIENCES
Filing DateMonday, February 24, 2020
Status700 - REGISTERED
Status DateTuesday, May 16, 2023
Registration Number7055715
Registration DateTuesday, May 16, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Description of MarkThe mark consists of the wording "AVIDITY" in an all-caps font where the "A" is formed by a down-facing angle. The wording "BIOSCIENCES" appears below in a smaller all-caps font. To the left of the wording is a highly stylized design of two curved ribbons forming a diamond or partial double-helix shape.
Goods and ServicesBiological, medicinal and pharmaceutical preparations, namely, oligonucleotide-based therapeutics for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOSCIENCES"
Goods and Servicesproviding medical and scientific research information in the fields of pharmaceuticals and biotechnology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 27, 2020
Primary Code005
First Use Anywhere DateThursday, November 4, 2021
First Use In Commerce DateThursday, November 4, 2021
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 27, 2020
Primary Code042
First Use Anywhere DateThursday, November 4, 2021
First Use In Commerce DateThursday, November 4, 2021

Trademark Owner History

Party NameAvidity Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAvidity Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAvidity Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Tuesday, May 16, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 16, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, April 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 4, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 30, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 30, 2023FINAL REFUSAL E-MAILED
Monday, January 30, 2023SU - FINAL REFUSAL - WRITTEN
Saturday, December 31, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 31, 2022ASSIGNED TO LIE
Friday, November 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 15, 2022NON-FINAL ACTION E-MAILED
Thursday, September 15, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, August 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, August 15, 2022USE AMENDMENT FILED
Tuesday, August 23, 2022SOU EXTENSION 4 GRANTED
Monday, August 15, 2022SOU EXTENSION 4 FILED
Tuesday, August 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 15, 2022TEAS EXTENSION RECEIVED
Monday, August 15, 2022TEAS STATEMENT OF USE RECEIVED
Friday, February 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU EXTENSION 3 GRANTED
Monday, February 14, 2022SOU EXTENSION 3 FILED
Monday, February 14, 2022TEAS EXTENSION RECEIVED
Wednesday, July 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 26, 2021SOU EXTENSION 2 GRANTED
Monday, July 26, 2021SOU EXTENSION 2 FILED
Monday, July 26, 2021TEAS EXTENSION RECEIVED
Friday, November 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 25, 2020SOU EXTENSION 1 GRANTED
Wednesday, November 25, 2020SOU EXTENSION 1 FILED
Wednesday, November 25, 2020TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 28, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, May 28, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 28, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, May 28, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION WRITTEN
Tuesday, May 12, 2020ASSIGNED TO EXAMINER
Friday, February 28, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 27, 2020NEW APPLICATION ENTERED

Related Keywords

biosciences avidity muscle diseases gastrointestinal hormonal dermatological neurological respiratory dysfunction oncological hepatological